FierceHealthcareFierceHealthITFierceHealthFinanceHospital Impact   FiercePharmaFierceBiotechFierceSarbox
Syndicate content

Sanofi Aventis news from FierceHealthcare

Most Popular Sanofi Aventis story
Related Tags Chiron   Vaccines   Department of Health and Human Services (HHS)   Food and Drug Administration (FDA)
Tools

News

ALSO NOTED: Plavix copycat on the rise in Europe; Hospital bills for services to dead patient; and much more...

May 9, 2008 — 6:59am ET
> Pharma giants Sanofi-Aventis and Bristol-Myers Squibb are preparing to battle a copycat generic to its Plavix brand. Read more...

Study:Hospital clot risks not always addressed

July 16, 2007 — 6:59am ET
While one in three U.S. hospital patients is at risk for blood cots, many of these patients don't get clot prevention treatment, says a new study. It's estimated 5 to 10 percent of hospital deaths... Read more...

Press Release: FDA Licenses First U.S. Vaccine For Humans Against Avian Influenza

April 18, 2007 — 10:43am ET | By Maureen Martino

Press Release: FDA Licenses First U.S. Vaccine For Humans Against Avian Influenza

... Read more...

ALSO NOTED: WSJ interviews HealthSouth CEO Jay Grinney; Avian flu vaccine faces challenges; and much more...

March 29, 2006 — 8:00pm ET

> The Wall Street Journal interviews HealthSouth CEO Jay Grinney today on the challenges facing the company in the post-Scrushy era. Article

> In a SEC filing, HealthSouth said it lost $485 million last year. Article

> A report in the New England Journal of Medicine …

... Read more...

Study questions Plavix-Asprin combination

March 12, 2006 — 8:01pm ET

A major study presented at the annual conference of the American College of Cardiology this weekend has created an uproar. The research finds that people who take the heart drug Plavix along with an Aspirin to decrease their chances of having a first heart attack are at risk of developing serious bleeding. The study examined a population of 15,000 subjects. Because earlier findings had suggested Plavix could have an excellent protective effect, the drug is commonly prescribed by …

... Read more...

HHS wants second avian flu vaccine

March 6, 2006 — 8:01pm ET

As evidence grows that the bird flu virus is mutating, Health and Human Services officials want work to begin on a new vaccine based on more recent strains. At an immunology conference in Atlanta, HHS Secretary Mike Leavitt said that in order to be prepared government scientists need to anticipate potential genetic changes that could transform the virus. The HHS authorized the National Institutes of Health and Centers for Disease Congrol to work on the new version found in Indonesia last …

... Read more...

Sanofi's H5N1 vaccine shows promise

December 14, 2005 — 8:01pm ET

French pharmaceutical company Sanofi-Aventis said that early stage trials of its experimental avian flu vaccine have produced promising results, triggering a good immune response in trial participants. The latest version of the vaccine appears to work well at low dosages, a sign that plans to stretch the available supply developed by public health officials could work. Officials admit that the vaccine will need to be tweaked to offer protection against a new strain of the H5N1 virus if a …

... Read more...

Chiron warns on vaccine production again

October 17, 2005 — 8:01pm ET

Vaccine maker Chiron said that it will not be able to meet its minimum production goal of 18 million doses in time for the 2005-06 flu season, again citing difficulties at its plant in the UK. CEO Howard Pien made the admission in a talk with analysts Monday but would not provide any additional details, leaving the extent of the shortage unknown. The news comes at a time when health officials are trying to calm public anxiety about the avian flu in the face of increasingly disturbing news …

... Read more...

Medicare Part D and big pharma

October 10, 2005 — 8:01pm ET

Despite the fact that many analysts see Medicare Part D as the biggest thing to happen to the pharmaceutical industry in years, pharma companies have been reluctant to talk about how much they stand to gain. Some even argue that in the end the benefit will end up hurting manufacturers more than it helps as customers move over to low-cost generics. Not many people buy that argument. Some analysts think the winners are likely to be companies like Sanofi-Aventis, Roche, Johnson & Johnson …

... Read more...

US releases pandemic plan

October 9, 2005 — 8:01pm ET

Over the weekend, with the bird flu threat getting major media play, details of the government's plan for coping with a pandemic were emerging. Officials said they expect local agencies to take the lead in the event of an outbreak. Less stress is placed on military involvement than critics had feared. The Department of Health and Human Services said it thinks a major outbreak could kill as many as 1.9 million Americans and affect about half the population. Anxiety was heightened by …

... Read more...
123next ›last »

Get more Sanofi Aventis coverage at:

FierceHealthFinance